Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

Bayer632 enrolled

Overview

The purpose of this study is to evaluate the symptoms and satisfaction for women taking drospirenone (DRSP)-containing combined oral contraceptives in comparison with women taking other kind of combined oral contraceptives.

Study Type

OBSERVATIONAL

Enrollment

632

Conditions

Contraception

Interventions

EE30-DRSP (Yasmin, BAY86-5131)DRUG

DRSP-containing combined oral contraceptives according to the normal routine praxis

Other combined oral contraceptivesDRUG

Other combined oral contraceptives according to the normal routine praxis

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * According to the label of the prescribed Combined Oral Contraceptive (COC) * first Combined Oral Contraceptive use or previous Combined Oral Contraceptive use * intention to use current COC for 1 year at least Exclusion Criteria: * Contraindications listed in the label of the prescribed Combined Oral Contraceptive (COC)

Locations (1)

Unnamed facility

Many Locations, Italy

Outcomes

Primary Outcomes

Psychophysical well-being evaluated by the Psychological General Well-Being Index (PGWBI)

Time frame: at 12 months

Sexual well-being evaluated by the Female Sexual Function Index (FSFI)

Time frame: at 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.